Why is Amerise BioScie falling/rising?

As of 22-Sep, Amerise Biosciences Ltd is currently priced at 0.70, showing no change (0.00%). The stock has underperformed its sector by 0.42% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past month, the stock has decreased by 9.09%, and year-to-date, it has fallen by 42.15%. Additionally, there has been a decline in investor participation, with delivery volume on 19 September decreasing by 0.82% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the stock's performance over the past week shows a flat return of 0.00%, while the benchmark Sensex has increased by 0.46%. This indicates that Amerise Biosciences Ltd is not only lagging behind the market but also struggling significantly over longer periods, with a year-to-date decline of 42.15% compared to the Sensex's gain of 5.15%. The stark contrast in performance suggests that the company is facing challenges that are not reflected in the broader market trends.